Chemotherapy News and Research

Latest Chemotherapy News and Research

Researchers learn to rapidly rebuild immunity in immune-suppressed cancer patients

Patients with multiple myeloma suffer from a malignant proliferation of plasma cells in their bone marrow. The standard treatment for this form of cancer is high-dose chemotherapy and transplantation of one's own blood-producing adult stem cells; however, this aggressive treatment wipes out the mature immune-system cells of patients – leaving them vulnerable to infection.

20 Oct 2005

Molecule P-glycoprotein (Pgp), may help reduce risk of Alzheimer's

A molecule that has long been an obstacle to cancer chemotherapy and drug treatments for brain disorders may soon become an ally in the fight against Alzheimer's disease, according to researchers at Washington University School of Medicine in St. Louis and the University of Rochester.

20 Oct 2005

Alzheimer disease and the blood brain barrier

Increased production of the amyloid-beta (Abeta) peptide can lead to Abeta aggregation and buildup in the brain and rare familial forms of early onset Alzheimer disease (AD).

20 Oct 2005

Diet rich in fruits and vegetables could be a good defense against prostate cancer

Previous studies have suggested that increased intake of flavonoids which are common in fruits and vegetables may be associated with a reduced risk of prostate cancer, according to Sanjay Gupta, Ph.D., an assistant professor in the Case School of Medicine Department of Urology.

20 Oct 2005

Breast cancer drug Herceptin a 'stunner'

According to the New England Journal of Medicine (NEJM) the first trials of the breast cancer drug, Herceptin, tested on women with early stage disease are "simply stunning".

20 Oct 2005

Distress caused by hot flushes seriously under-played

A study by UK researchers of over 200 breast cancer patients receiving hormone treatments such as tamoxifen has found that nearly two-thirds would prefer to take a tablet daily and around a quarter would prefer a monthly injection, given that both treatments would be equally effective and have similar side-effects.

19 Oct 2005

Herceptin results "quite remarkable"

The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage disease when given for one year following standard chemotherapy.

19 Oct 2005

Herceptin therapy highly superior to standard breast cancer treatment

In a joint paper, co-authored by Mayo Clinic's Edith Perez, M.D., and Edward Romond, M.D., of the National Surgical Adjuvant Breast and Bowel Project (NSABP), researchers report complete and combined results of two trials comparing adjuvant chemotherapy with or without concurrent trastuzumab treatment in women with surgically removed HER2-positive breast cancer.

19 Oct 2005

Majority of women with breast cancer do not need chemotherapy

Researchers are now saying that chemotherapy with drugs called aromatase inhibitors is unnecessary after lumpectomy, radiation and 5 years of Tamoxifen, for the vast majority of women with breast cancer.

19 Oct 2005

Court victory means breast cancer drug Herceptin will be available to more women

The court victory of British woman Barbara Clark to be treated with the breast cancer drug Herceptin, means that now more than 100 breast cancer patients in Cornwall and Devon could soon be prescribed the drug.

19 Oct 2005

Yeast cells help show how GSAO (glutathionarsenoxide) angiogenesis inhibitor drug works

The humble yeast has revealed the molecular workings of an anti-cancer drug that stops the growth and spread of tumours in humans by starving their blood supply.

18 Oct 2005

Intensity modulated radiation therapy (IMRT) for head and neck cancer

Results from a University of Pittsburgh study evaluating intensity modulated radiation therapy (IMRT) for head and neck cancer determined the ideal doses for lessening treatment side effects. The findings were presented today at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Denver.

18 Oct 2005

Possible new combination treatment regimen for patients with head and neck cancers who develop a second tumor

Few treatment options exist for patients with head and neck cancers who develop a second tumor or whose disease recurs in an area that has previously received radiation. Data from an international study reveal a possible new combination treatment regimen that offers a significant survival advantage for many of these patients.

18 Oct 2005

Study shows possibilities for curing patients with early-stage Hodgkin's lymphoma of their cancer

Doctors in Germany have determined that patients suffering from early-stage Hodgkin's lymphoma can receive a reduced dose of involved field radiation therapy, combined with chemotherapy, and still retain a high survival rate, according to a study presented October 17, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.

17 Oct 2005

New approaches to counteract platelet shortages

Availability of safe platelets is a fundamental blood transfusion challenge and can be especially problematic in times of emergency. Several studies presented at the annual American Association of Blood Banks (AABB) meeting today demonstrate new approaches to counteract platelet shortages by enhancing the safety of whole blood derived platelets, precluding the need to rely on only those obtained through apheresis.

17 Oct 2005

New tool that may prove to be invaluable for investigating the long-term mutagenic effects of chemotherapy and radiation

Scientists have developed a new tool that may prove to be invaluable for investigating the long-term mutagenic effects of chemotherapy and radiation, therapies that are widely used for the treatment of cancer.

17 Oct 2005

Radiation therapy combined with chemotherapy before surgery helps patients beat rectal cancer

For patients with rectal cancer, receiving radiation therapy and chemotherapy before surgery to shrink the tumor so it can be more easily removed helps keep the cancer from coming back, according to a study presented October 17, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.

17 Oct 2005

WWOX gene finding could lead to a new strategy for treating lung cancer

The research focused on a gene known as WWOX, which is lost or silenced in a large majority of lung cancers, and in cancers of the breast, ovary, prostate, bladder, esophagus and pancreas. The work was led by scientists at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

17 Oct 2005

New findings on brain tumors called ependymomas

Brain tumors called ependymomas that occur in different parts of the central nervous system appear to arise from subpopulations of stem cells called radial glia cells (RGCs), according to investigators at St. Jude Children's Research Hospital. The discovery explains why some identical-looking ependymomas are actually distinctly different diseases, the researchers said.

17 Oct 2005

Curry spice appears to shut down a protein active in the spread of breast cancer

Curcumin, the main ingredient of turmeric and the compound that gives curry its mustard-yellow color, inhibits metastasis to the lungs of mice with breast cancer, report researchers at The University of Texas M. D. Anderson Cancer Center

16 Oct 2005

Chemotherapy News and Research

Latest Chemotherapy News and Research

Researchers learn to rapidly rebuild immunity in immune-suppressed cancer patients

Molecule P-glycoprotein (Pgp), may help reduce risk of Alzheimer's

Alzheimer disease and the blood brain barrier

Diet rich in fruits and vegetables could be a good defense against prostate cancer

Breast cancer drug Herceptin a 'stunner'

Distress caused by hot flushes seriously under-played

Herceptin results "quite remarkable"

Herceptin therapy highly superior to standard breast cancer treatment

Majority of women with breast cancer do not need chemotherapy

Court victory means breast cancer drug Herceptin will be available to more women

Yeast cells help show how GSAO (glutathionarsenoxide) angiogenesis inhibitor drug works

Intensity modulated radiation therapy (IMRT) for head and neck cancer

Possible new combination treatment regimen for patients with head and neck cancers who develop a second tumor

Study shows possibilities for curing patients with early-stage Hodgkin's lymphoma of their cancer

New approaches to counteract platelet shortages

New tool that may prove to be invaluable for investigating the long-term mutagenic effects of chemotherapy and radiation

Radiation therapy combined with chemotherapy before surgery helps patients beat rectal cancer

WWOX gene finding could lead to a new strategy for treating lung cancer

New findings on brain tumors called ependymomas

Curry spice appears to shut down a protein active in the spread of breast cancer

Cancer Research - Second Edition eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in